376 related articles for article (PubMed ID: 31577122)
1. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
[TBL] [Abstract][Full Text] [Related]
2. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
[TBL] [Abstract][Full Text] [Related]
3. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
4. Tannic Acid (TA)-Functionalized Magnetic Nanoparticles for EpCAM-Independent Circulating Tumor Cell (CTC) Isolation from Patients with Different Cancers.
Ding P; Wang Z; Wu Z; Hu M; Zhu W; Sun N; Pei R
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3694-3700. PubMed ID: 33442969
[TBL] [Abstract][Full Text] [Related]
5. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
[TBL] [Abstract][Full Text] [Related]
6. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
[TBL] [Abstract][Full Text] [Related]
7. Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection.
Jia F; Wang Y; Fang Z; Dong J; Shi F; Zhang W; Wang Z; Hu Z
Anal Chem; 2021 Apr; 93(14):5670-5675. PubMed ID: 33788544
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
9. Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles.
Jiang X; Zhang X; Guo C; Liu Z; Guo X; Tian Z; Wang Z; Yang J; Huang X; Ou L
J Nanobiotechnology; 2024 May; 22(1):231. PubMed ID: 38720360
[TBL] [Abstract][Full Text] [Related]
10. Multi-targeting magnetic hyaluronan capsules efficiently capturing circulating tumor cells.
Ma S; Zhou X; Chen Q; Jiang P; Lan F; Yi Q; Wu Y
J Colloid Interface Sci; 2019 Jun; 545():94-103. PubMed ID: 30875509
[TBL] [Abstract][Full Text] [Related]
11. A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers.
Wu Z; Pan Y; Wang Z; Ding P; Gao T; Li Q; Hu M; Zhu W; Pei R
J Mater Chem B; 2021 Mar; 9(9):2212-2220. PubMed ID: 33616137
[TBL] [Abstract][Full Text] [Related]
12. Dual-antibody Modified PLGA Nanofibers for Specific Capture of Epithelial and Mesenchymal CTCs.
Liu H; Wang Z; Chen C; Ding P; Sun N; Pei R
Colloids Surf B Biointerfaces; 2019 Sep; 181():143-148. PubMed ID: 31128514
[TBL] [Abstract][Full Text] [Related]
13. Antifouling hydrogel-coated magnetic nanoparticles for selective isolation and recovery of circulating tumor cells.
Wang Z; Wu Z; Sun N; Cao Y; Cai X; Yuan F; Zou H; Xing C; Pei R
J Mater Chem B; 2021 Jan; 9(3):677-682. PubMed ID: 33333542
[TBL] [Abstract][Full Text] [Related]
14. Vertical Magnetic Separation of Circulating Tumor Cells for Somatic Genomic-Alteration Analysis in Lung Cancer Patients.
Yoo CE; Park JM; Moon HS; Joung JG; Son DS; Jeon HJ; Kim YJ; Han KY; Sun JM; Park K; Park D; Park WY
Sci Rep; 2016 Nov; 6():37392. PubMed ID: 27892470
[TBL] [Abstract][Full Text] [Related]
15. Gelatin Nanoparticle-Coated Silicon Beads for Density-Selective Capture and Release of Heterogeneous Circulating Tumor Cells with High Purity.
Huang Q; Wang FB; Yuan CH; He Z; Rao L; Cai B; Chen B; Jiang S; Li Z; Chen J; Liu W; Guo F; Ao Z; Chen S; Zhao XZ
Theranostics; 2018; 8(6):1624-1635. PubMed ID: 29556345
[No Abstract] [Full Text] [Related]
16. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
Jia M; Mao Y; Wu C; Wang S; Zhang H
Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
[TBL] [Abstract][Full Text] [Related]
17. Size-matching hierarchical micropillar arrays for detecting circulating tumor cells in breast cancer patients' whole blood.
Wang Z; Xu D; Wang X; Jin Y; Huo B; Wang Y; He C; Fu X; Lu N
Nanoscale; 2019 Apr; 11(14):6677-6684. PubMed ID: 30899928
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on antibody immobilization strategies for efficient circulating tumor cell capture.
Ates HC; Ozgur E; Kulah H
Biointerphases; 2018 Mar; 13(2):021001. PubMed ID: 29571263
[TBL] [Abstract][Full Text] [Related]
19. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
Johnson ES; Anand RK; Chiu DT
Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
[TBL] [Abstract][Full Text] [Related]
20. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
